Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications

E Schramm, DN Klein, M Elsaesser… - The Lancet …, 2020 - thelancet.com
Persistent depressive disorder is a chronic mood disorder that is common and often more
disabling than episodic major depression. In DSM-5, the term subsumes several chronic …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

[HTML][HTML] Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis

JEJ Buckman, A Underwood, K Clarke… - Clinical psychology …, 2018 - Elsevier
Purpose To review and synthesise prognostic indices that predict subsequent risk,
prescriptive indices that moderate treatment response, and mechanisms that underlie each …

Mitochondrial dysfunction in depression

Y Bansal, A Kuhad - Current neuropharmacology, 2016 - ingentaconnect.com
Background: Depression is the most debilitating neuropsychiatric disorder with significant
impact on socio-occupational and well being of individual. The exact pathophysiology of …

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal ' …

A Cattaneo, M Gennarelli, R Uher, G Breen… - …, 2013 - nature.com
To improve the 'personalized-medicine'approach to the treatment of depression, we need to
identify biomarkers that, assessed before starting treatment, predict future response to …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines

A Cleare, CM Pariante, AH Young… - Journal of …, 2015 - journals.sagepub.com
A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …

Glucocorticoids, cytokines and brain abnormalities in depression

PA Zunszain, C Anacker, A Cattaneo… - Progress in Neuro …, 2011 - Elsevier
Major depression (MD) is a common psychiatric disorder with a complex and multifactor
aetiology. Potential mechanisms associated with the pathogenesis of this disorder include …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

IM Anderson, IN Ferrier, RC Baldwin… - Journal of …, 2008 - journals.sagepub.com
A revision of the 2000 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken to …

Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder

E Alcocer-Gómez, N Casas-Barquero… - Pharmacological …, 2017 - Elsevier
Abstract Major Depressive Disorder (MDD, ICD-10: F-33) is a prevalent illness in which the
pathogenic mechanism remains elusive. Recently an important role has been attributed to …

Weight gain and antidepressants

M Fava - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …